Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Sensitisation data (human)

Currently viewing:

Administrative data

Endpoint:
sensitisation data (humans)
Type of information:
experimental study
Adequacy of study:
supporting study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
study well documented, meets generally accepted scientific principles, acceptable for assessment

Data source

Reference
Reference Type:
publication
Title:
Allergic contact dermatitis from povidone-iodine
Author:
Erdmann S., Hertl M., Merk H.F.
Year:
1999
Bibliographic source:
Contact Dermatitis 1999: 40: 331

Materials and methods

Type of sensitisation studied:
skin
Study type:
case report
Principles of method if other than guideline:
2 cases of post-operative dermatitis due to povidone iodine were presented. Patch tests with the test substance were performed.
GLP compliance:
no

Test material

Constituent 1
Reference substance name:
Reaction mass of iodine and 2-Pyrrolidinone, 1-ethenyl-, homopolymer
EC Number:
913-404-5
Molecular formula:
Unspecified
IUPAC Name:
Reaction mass of iodine and 2-Pyrrolidinone, 1-ethenyl-, homopolymer
Details on test material:
- Purity: ≥ 92%- pH: ≥ 1 - ≤ 5 (aqueous preparation)
Specific details on test material used for the study:
- Name of test substance: povidone-iodine

Method

Type of population:
general
Ethical approval:
not specified
Subjects:
Case 1: A 16-year-old boy
Case 2: A 62-year-old man
Clinical history:
Case 1: A 16-year-old boy presented with post-operative dermatitis on the distal right foot, after surgery on the right big toe nail, which had been treated with 10% PVP-I (Freka-cid cream). This treatment was stopped and, with oral prednisolone for 1 week, the dermatitis gradually resolved. Case 2: The 62-year-old man had been treated on the right flank with povidone-iodine (Betaisodona solution, also marketed as Betadine solution) prior to surgery on the left kidney. Within 24 h after the operation, he developed allergic contact dermatitis at the site where the antiseptic solution had been applied. With topical corticosteroids, the contact dermatitis gradually resolved.
Route of administration:
dermal
Details on study design:
Case 1 was patch tested with the following substances:Freka-cid cream (undiluted)- 5% Povidone-iodine (aqueous)- 10% Povidone-iodine (aqueous)- 5% Povidone-iodine (in petrolatum)- 10% Povidone-iodine (in petrolatum)- 0.5% Iodine (in petrolatum)- Povidone (undiluted)- All other constituents of Freka-acid cream
Case 2 was patch tested with the following substances:- Betaisodona solution (undiluted)- 10% Povidone-iodine (aqueous)- 0.5% Iodine (in petrolatum)- Povidone (undiluted)- all other constituents of Betaisodona solution

Results and discussion

Results of examinations:
Case 1: Patch testing with Freka-cid cream and all its constituents supplied by the manufacturer revealed positive reactions to Freka-cid and Povidone-iodine. Additional patch testing with a commercial series of common antiseptics showed a positive reaction to iodine. Case 2: Patch testing with Betaisodona solution and all its constituents supplied by the manufacturer revealed positive reactions to Betaisodona solution and Povidone-iodine. Additional patch testing with a commercial series of common antiseptics showed a positive reaction to iodine.

Applicant's summary and conclusion